From 300 to 20,149 Jan Aushadhi Kendras: How PMBJP is transforming affordable healthcare across India

Key Highlights

  • New Delhi: In a written reply to the Lok Sabha on July 24,
  • Union Minister for Chemicals and Fertilisers Jagat Prakash Nadda placed on record a milestone that has reshaped healthcare economics for crores of Indian households over the past twelve years: the Pradhan Mantri Bhartiya Janaushadhi Pariyoja...
Advertisement
Ad Space ()

From 300 to 20,149 Jan Aushadhi Kendras: A Paradigm Shift in Healthcare Affordability

In a significant disclosure to the Lok Sabha on July 24, Union Minister for Chemicals and Fertilisers Jagat Prakash Nadda highlighted a transformative milestone for India’s public health infrastructure. The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) has reached a total of 20,149 operational Jan Aushadhi Kendras (JAKs) as of June 30, 2026. Spanning 776 of India’s 784 districts, this expansive network has fundamentally altered the economics of medical care, resulting in an estimated Rs 45,000 crore in savings for citizens through the provision of affordable, quality-assured generic medicines.

What began as a modest experiment in 2008 has, through sustained policy focus and administrative agility, evolved into one of the world’s most extensive publicly-backed pharmacy networks. The growth trajectory has been nothing short of exponential: from barely a few hundred stores in its early years to 7,836 by mid-2021, and now crossing the 20,000-store threshold. This compounding momentum underscores a shift in how essential healthcare is delivered to the doorstep of the common citizen.

Scaling Access Through Quality and Diversity

The success of the PMBJP is rooted in its ability to bridge the gap between affordability and quality. Currently, the scheme’s product basket includes 2,110 medicines and 315 surgical items, encompassing treatment categories ranging from cardiovascular diseases and diabetes to oncology and gastro-intestinal ailments. By covering almost every essential medicine listed in the National List of Essential Medicines, the scheme ensures that comprehensive treatment is not a luxury reserved for the affluent.

Crucially, the government has addressed historical skepticism regarding the quality of generic drugs through a rigorous supply chain architecture. Every medicine stocked at a Jan Aushadhi Kendra is sourced from manufacturers certified under World Health Organisation (WHO) Good Manufacturing Practices. Furthermore, every individual batch undergoes testing at laboratories accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL). This commitment to quality has been central to building public trust, effectively dispelling the notion that lower prices necessarily equate to inferior efficacy.

Empowering Rural Economies and Entrepreneurs

Beyond its public health impact, the PMBJP functions as a robust entrepreneurship engine. The model operates on a franchise basis, allowing individual entrepreneurs, NGOs, and cooperatives to manage Kendras, thereby creating sustainable livelihoods. The government has further incentivized this by providing one-time financial support of up to Rs 2 lakh for infrastructure and equipment, specifically targeting women, persons with disabilities, ex-servicemen, and entrepreneurs in Aspirational Districts and the North-East.

A notable development in recent months has been the integration of Jan Aushadhi Kendras with Primary Agriculture Credit Societies (PACS). This move is particularly significant for the agricultural sector, as it allows rural cooperatives to diversify their income streams while simultaneously improving access to essential medicines in underserved rural pockets. By embedding pharmacy services within the established rural cooperative framework, the government is ensuring that the benefits of the scheme penetrate the deepest layers of the Indian hinterland.

What This Means for Farmers

For the farming community, the expansion of the PMBJP network offers both immediate financial relief and long-term socioeconomic benefits:

  • Mitigating Out-of-Pocket Expenditure: Agricultural households often face the brunt of high out-of-pocket health expenses, which can lead to debt cycles during medical emergencies. With Jan Aushadhi medicines priced 50 to 80 percent lower than branded equivalents, farming families can significantly reduce their non-farm expenditure, freeing up capital for essential farm inputs like quality seeds, fertilizers, and irrigation equipment.
  • Rural Accessibility: The integration of Kendras with Primary Agriculture Credit Societies brings pharmacy services closer to the farm gate. This reduces the time and transportation costs associated with traveling to urban centers to procure chronic medications for hypertension, diabetes, or common infections.
  • Diversified Income for Cooperatives: For members of rural cooperatives and PACS, the PMBJP franchise model provides a stable, government-backed business opportunity. This helps in strengthening the rural cooperative movement, providing a reliable retail income that is less volatile than seasonal agricultural produce markets.
  • Improved Preventive Health: With the inclusion of nutraceuticals and essential health products—such as the Jan Aushadhi Suvidha sanitary napkins—the scheme promotes holistic wellness within rural families, contributing to a healthier and more productive agricultural workforce.

In essence, the PMBJP is no longer just a healthcare scheme; it is a structural support system that protects the disposable income of India’s rural population, allowing for greater investment in the very land that feeds the nation.